This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 40
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

To evaluate the effectiveness of Gelsemium sempervirens 5CH et 15CH on anticipatory provoked anxiety, in healthy volunteers.

Provided treatments

  • Drug: Gelsemium Sempervirens
  • Drug: Gelsemium Sempervirens
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT00914329. The sponsor of the trial is University Hospital, Grenoble and it is looking for 180 volunteers for the current phase.
Official trial title:
Randomized Controlled Study Versus Placebo Evaluating Effectiveness of Gelsemium Sempervirens (5CH et 15CH) on Provoked Anticipatory Anxiety, in Healthy Volunteers